ESCAPE-NA1 Trial
Trial site participants
The ESCAPE-NA1 Trial is a multicentre, randomized, double-blinded, placebo-controlled, parallel group, single-dose design to determine the efficacy and safety of intravenous NA-1 in subjects with acute ischemic stroke undergoing endovascular thrombectomy.
For more information about the trial, contact:
University of Calgary Coordinating Site
Room C1241B-1403-29th Street NW
Foothills Medical Centre
403-944-2863 ( office)
Email: esctrial@ucalgary.ca
Please contact the trial office for access to documents and resources.